financetom
Business
financetom
/
Business
/
Boeing Commercial Airplanes Business to Continue Improving Margins, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boeing Commercial Airplanes Business to Continue Improving Margins, RBC Says
Jul 30, 2025 9:50 AM

12:25 PM EDT, 07/30/2025 (MT Newswires) -- Boeing's ( BA ) commercial airplanes segment led the company's Q2 growth and its margins are expected to continue improving, RBC Capital Markets said in a Tuesday note.

The investment firm said the company reported a "relatively strong" Q2, as core loss narrowed to $1.24 per share from $2.90 a year earlier and revenue increased to $22.75 billion from $16.87 billion. Boeing Commercial Airplanes or BCA saw an 81% growth during the quarter, RBC said.

RBC also highlighted the company's Q2 free cash flow of negative $200 million, which is more than $1 billion better than expectations. And while Boeing ( BA ) projects positive free cash flow in H2, RBC said the company's outlook implies a "conservative" Q4 guidance of about $500 million during this "seasonally" strong quarter.

RBC Capital Markets reiterated its outperform rating and $250 price target on Boeing ( BA ).

Price: 228.17, Change: +2.09, Percent Change: +0.92

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TD Comments on Bank of Canada After Labor Data
TD Comments on Bank of Canada After Labor Data
Dec 9, 2024
08:34 AM EST, 12/09/2024 (MT Newswires) -- Investors had plenty to digest with Friday's Canadian Labour Force Survey (LFS), said TD. The unemployment rate climbed to 6.8% -- its highest level since January 2017, excluding the pandemic. This nudged the odds of a 50bps rate cut up to 80% on Friday from what was previously a near coin flip, noted...
IDEAYA Biosciences Nominates IDE892 as Development Candidate
IDEAYA Biosciences Nominates IDE892 as Development Candidate
Dec 9, 2024
08:33 AM EST, 12/09/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) said Monday it nominated IDE892 as a development candidate, which it said is a potential methylthioadenosine-cooperative PMRT5 inhibitor. The oncology company said IDE892 has demonstrated exceptionally selective antiproliferative activity in MTAP-deleted tumor cell models. IDEAYA said ongoing studies of IDE892 are intended to support an investigational new drug...
BP forms offshore wind joint venture in renewables retreat
BP forms offshore wind joint venture in renewables retreat
Dec 9, 2024
* JV to merge capacity of up to 13 gigawatts * 50-50 JV to spend up to $5.8 bln by 2030 * Major step in BP CEO's strategy to reduce renewables' focus (Adds JERA CEO comment, Jera Nex bp CEO name, background on Shell, updates shares) By Ron Bousso and Yuka Obayashi LONDON, Dec 9 (Reuters) - BP and Japanese...
AngioDynamics' NanoKnife System Receives FDA Clearance for Prostate Tissue Ablation
AngioDynamics' NanoKnife System Receives FDA Clearance for Prostate Tissue Ablation
Dec 9, 2024
08:36 AM EST, 12/09/2024 (MT Newswires) -- AngioDynamics ( ANGO ) said Monday its NanoKnife System received 510(k) clearance from the US Food and Drug Administration for prostate tissue ablation. The clearance was based on the company's Preserve clinical study and submission of results to the regulator in September, which evaluated NanoKnife's safety and effectiveness in participants with intermediate-risk prostate...
Copyright 2023-2026 - www.financetom.com All Rights Reserved